Kelly is a Specialist Leader with Deloitte’s Life Sciences R&D Strategy & Operations practice and has a combined 17 years of industry and consulting experience concentrated in the area of Drug Safety, Regulatory Affairs and Quality Management. Kelly has lead projects focused in the areas of operational excellence and process optimization including various operating model assessment and implementations, business process analysis/redesign projects, license partner and vendor set-up and management. Kelly has also has extensive experience in Standard Operating Procedure, and Work instruction writing and training. Kelly brings in depth industry knowledge and awareness to help clients define their goals and objectives to stay aligned with industry-leading practices and to remain competitive in the marketplace